CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Net revenue	$ 52,036	$ 41,371
Cost of goods sold	8,906	6,791
Gross profit	43,130	34,580
Operating expenses
Research and development costs	7,049	5,773
Selling, general, and administrative	43,820	37,242
Total operating expenses	50,869	43,015
Operating loss	(7,739)	(8,435)
Other expense
Other expense	(179)	(101)
Interest expense, net	(1,205)	(668)
Total other expense	(1,384)	(769)
Loss before income taxes	(9,123)	(9,204)
Income tax (benefit) expense	(71)	32
Net loss	(9,052)	(9,236)
Foreign currency translation adjustment	(99)	(324)
Comprehensive loss	$ (9,151)	$ (9,560)
Weighted average number of shares of common stock outstanding:
Basic	80,681,715	76,447,454
Diluted	80,681,715	76,447,454
Net loss per share attributable to common stockholders:
Basic	$ (0.11)	$ (0.12)
Diluted	$ (0.11)	$ (0.12)